Select Conferences

Siemens and LabCorp Enter Agreement to Co-Develop Clinical Diagnostic Tests
Companies to plan co-development of new clinical diagnostic tests in the areas of companion diagnostics, metabolic syndrome, oncology and diabetes.

Champions Biotechnology and ImClone Systems Establish Agreement for Preclinical Evaluation of Oncology Drugs
As part of the agreement, ImClone will utilize Champions Biotechnology's Biomerk Tumorgrafts™ in the initial preclinical evaluation.

DiaKine Therapeutics and Kinexum Metabolics to Develop Combination Treatment to Type 1 Diabetes
DiaKine’s Lisofylline and Kinexum’s INGAP peptide combo therapy is set for Phase 2 clinical trial.

Caliper LS and DiscoveRx Collaborate to Offer Solutions for Cell-Based GPCR Profiling and Lead Optimization
The combined offering bundles Caliper LabChip systems with DiscoveRx’s cellular assays, including PathHunter™ B Arrestin and cAMP Hunter™.

Malvern Instruments Presentation Shows Power of Near-infrared Chemical Imaging in Quality by Design
The presentation highlights, how SyNIRgi NIR-CI system can provide the data and product understanding required for Quality by Design.

Syndexa Pharmaceuticals Corporation and ChemDiv Announce Discovery Collaboration
ChemDiv will discover small molecule ligands for biotargets nominated by Syndexa.

BioSeek Initiates Research Collaboration with Lexicon Pharmaceuticals
BioSeek’s BioMAP® Systems will be used to help further evaluate selected compounds associated with several of Lexicon’s drug discovery programs.

3rd Annual Biomarkers Congress,14 & 15 May 2008, Manchester, UK
14 May 2008 - 15 May 2008

The conference programme will feature keynote addresses, case study presentations, panel and roundtable discussions from over 65 speakers in Biomarker Discovery and Validation, Molecular Diagnostics, Data Integration, Modelling and Bioinformatics, Imaging, Clinical Development and Toxicity Biomarkers.

Computational Aspects - Biomolecular NMR, Lucca Barga, Italy
18 May 2008 - 23 May 2008

The Gordon Research Conference on Computational Aspects of Biomolecular NMR provides a unique forum to discuss newly emerging computational and experimental methods that will drive NMR applications toward ever more complex and challenging biomolecular systems.

Lead-Finding Screening, London, UK
19 May 2008 - 21 May 2008

Enhance your lead discovery strategy and produce the quality leads you want by choosing the right assays and follow-up tools.

Personalised Medicine, London, UK
22 May 2008 - 23 May 2008

Optimising the efficiency of your R&D strategy through effective investment into the tailored and personalised medicine arena.

Permanent Senior Scientist Position in NMR-based Metabolomics
CIBERDEM
Tarragona, Spain

BBSRC Funded Microfluidics Engineering Resarch PhD
University College London
London, UK

Post-Doctpral Position in Mollusk Health Laboratory
UPEI
Charlottetown, Canada

Production Chemist II
Independent
Torrance, CA, USA

Research Chemist
Independent
Torrance, CA, USA

phD Scholarship in BioInformatics
Universitat Rovira i Virgili
Tarragona, Spain

QC Analyst
Genomic Health
Redwood City, CA, USA

Research Scientist II - Biology
Gilead Sciences
Foster City, CA, USA

High Throughput Coordinator / Engineer
AJI
Houston, TX, USA

Assistant Director, Automation Services
Medarex, Inc.
Milpitas, CA, USA

Protein Crystallographer
BioAlliance
La Jolla, CA, USA

Regulatory Services Business Development
Recruiter: VRS Regulatory
Central Scotland, UK

Genetic Algorithms Successfully Select Potential Biomarkers in Mass Spectrometry-Based Metabolomics
UC Davis Genome Center

Combination of the comprehensive metabolic profiling utilizing three complementary analytical methods for MS data acquisition and Genetic Algorithms technique for feature selection presenting intriguing avenue for finding and exploration small subsets of strong classifiers.

Bio-analytic silicon chips for the detection of developmentalneurotoxic effects of chemicals and drugs in the context of the European REACH program
University of Rostock, Bionas GmbH

Bio-analytic silicon chips can be used to investigate stem cell differentiation into neurons and for the in vitro on-line monitoring of cellular reactions under well controlled experimental conditions. Chip systems allow for a parallel, label-free and non-invasive measurement of different parameters by CMOS silicon microsensors by the application of potential neurotoxic and developmental neurotoxic substances.

Bio-analytic silicon chips for the detection of developmentalneurotoxic effects of chemicals and drugs in the context of the European REACH program
University of Rostock, Bionas GmbH

Bio-analytic silicon chips can be used to investigate stem cell differentiation into neurons and for the in vitro on-line monitoring of cellular reactions under well controlled experimental conditions. Chip systems allow for a parallel, label-free and non-invasive measurement of different parameters by CMOS silicon microsensors by the application of potential neurotoxic and developmental neurotoxic substances.
  


Metabolomics Strategy to Identify Tissue Specific Drug Effects

Matej Orešic, Chief Research Scientist, VTT Technical Research Centre, speaking at the European Biomarker Summit, 2007


Novel Biomarker Discovery Using Metabolomics

Felice de Jong, Director, Metabolon Inc. speaking at the European Biomarkers Summit 2006.

High-Throughput Method for Dynamic Measurements of Cellular Viability Using a FLUOstar OPTIMA
BMG LABTECH

We show that the propidium iodide (PI) assay performed on the FLUOstar OPTIMA from BMG LABTECH is a very useful tool for monitoring neuronal viability. It allows a complete analysis of the dynamics of the response to a specific substance.
Numerous parameters, including lag times and rates of death can be assessed using this PI method. The FLUOstar OPTIMA is a flexible microplate reader able to record PI fluorescence over very long periods.

A global abstract analysis of selected histone-modifying enzymes using AKS
Active Motif

A global abstract analysis (GAA) was performed on twelve histone-modifying enzymes (ASH1, CARM1, CBP, CKII, EZH2, MSK1, MST1, NSD1, PCAF, RIZ1, SIRT2 and TIP60) to demonstrate how this approach can help uncover biological relationships, scientific information, and overall publication trends from PubMed abstracts and related biological databases. This GAA study showed that published research of histone-modifying enzymes has increased significantly since 2001 and that many reported studies have fo

Biomarkers and Related Tests for Molecular Diagnostics and Pharma/ Biotech R&D
Published July 2005

This report maps out the major areas of the market ecosystem for biomarkers and related tests. This insightful study shows that this market is big business and reached $7.1 billion in 2004. The study reveals that molecular diagnostic companies are poised for continued strong growth. The mix of pharma/ biotech companies doing biomarker related R&D is also beginning to show gains.